chr16-575959-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004204.5(PIGQ):​c.810C>T​(p.Ala270Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00616 in 1,584,596 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 2 hom., cov: 34)
Exomes 𝑓: 0.0064 ( 52 hom. )

Consequence

PIGQ
NM_004204.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.75
Variant links:
Genes affected
PIGQ (HGNC:14135): (phosphatidylinositol glycan anchor biosynthesis class Q) This gene is involved in the first step in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes a N-acetylglucosaminyl transferase component that is part of the complex that catalyzes transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 16-575959-C-T is Benign according to our data. Variant chr16-575959-C-T is described in ClinVar as [Benign]. Clinvar id is 456054.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.75 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00393 (599/152320) while in subpopulation SAS AF= 0.0141 (68/4830). AF 95% confidence interval is 0.0114. There are 2 homozygotes in gnomad4. There are 287 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGQNM_004204.5 linkc.810C>T p.Ala270Ala synonymous_variant Exon 3 of 11 ENST00000321878.10 NP_004195.2 Q9BRB3-2B2RAU6
PIGQNM_148920.4 linkc.810C>T p.Ala270Ala synonymous_variant Exon 3 of 10 NP_683721.1 Q9BRB3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGQENST00000321878.10 linkc.810C>T p.Ala270Ala synonymous_variant Exon 3 of 11 1 NM_004204.5 ENSP00000326674.6 Q9BRB3-2

Frequencies

GnomAD3 genomes
AF:
0.00393
AC:
598
AN:
152202
Hom.:
2
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00135
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00294
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0139
Gnomad FIN
AF:
0.00367
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00556
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00545
AC:
1104
AN:
202462
Hom.:
8
AF XY:
0.00628
AC XY:
684
AN XY:
108844
show subpopulations
Gnomad AFR exome
AF:
0.00136
Gnomad AMR exome
AF:
0.00167
Gnomad ASJ exome
AF:
0.00166
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0178
Gnomad FIN exome
AF:
0.00274
Gnomad NFE exome
AF:
0.00555
Gnomad OTH exome
AF:
0.00559
GnomAD4 exome
AF:
0.00639
AC:
9156
AN:
1432276
Hom.:
52
Cov.:
33
AF XY:
0.00678
AC XY:
4814
AN XY:
709772
show subpopulations
Gnomad4 AFR exome
AF:
0.00118
Gnomad4 AMR exome
AF:
0.00204
Gnomad4 ASJ exome
AF:
0.00145
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0191
Gnomad4 FIN exome
AF:
0.00302
Gnomad4 NFE exome
AF:
0.00626
Gnomad4 OTH exome
AF:
0.00591
GnomAD4 genome
AF:
0.00393
AC:
599
AN:
152320
Hom.:
2
Cov.:
34
AF XY:
0.00385
AC XY:
287
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.00135
Gnomad4 AMR
AF:
0.00294
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0141
Gnomad4 FIN
AF:
0.00367
Gnomad4 NFE
AF:
0.00556
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.00471
Hom.:
3
Bravo
AF:
0.00350
Asia WGS
AF:
0.00462
AC:
16
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

PIGQ-related disorder Benign:1
Feb 01, 2024
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Epilepsy Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Developmental and epileptic encephalopathy, 77 Benign:1
Nov 12, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
6.7
DANN
Benign
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35227916; hg19: chr16-625959; API